3D Spheroid HepaRG and Fluorescent Biphasic Tracer for CYP3A4-mediated Antibiotic Interaction Monitoring in Sepsis

Overview

Journal Anal Bioanal Chem

Specialty Chemistry

Date 2024 Jun 5

PMID 38839687

Authors

Jiaan Qin

Ying Zhang

Jiayu Zeng

Yingchang Song

Dan Yan

Affiliations

Soon will be listed here.

Abstract

Cytochrome P450 3A4 (CYP3A4) is a crucial enzyme in the metabolism of xenobiotics, particularly in drug metabolism interactions (DDIs), making it a significant factor in clinical drug use. However, current assay techniques are both laborious and costly, making it difficult to construct a high-throughput monitoring method that can be used in conjunction with the clinic. This poses certain safety hazards for drug combination. Therefore, it is crucial to develop a synchronized monitoring method for the inhibition and induction of CYP3A4. In this study, we utilized 3D culture technology to develop a HepaRG cells spheroid model. The CYP450 and transporter expression, the albumin secretion, and urea synthesis capacity characteristics were analyzed. The NEN probe was utilized as a tracer molecule for CYP3A4. The fluorescence intensity of metabolites was characterized by laser confocal technique to determine the inhibition and expression of CYP3A4 in the HepaRG cell spheroid model by the antibiotics for sepsis. The results indicate that the HepaRG sphere model successfully possessed the physiological phenotype of the liver, which could be used for drug interaction monitoring. Through positive drug testing, NEN probe was able to achieve bidirectional characterization of CYP3A4 induction and inhibition. The monitoring method described in this paper was successfully applied to drug interaction monitoring of commonly used antibiotics in sepsis patients, which is a convenient and rapid monitoring method. The proposed method offers a new strategy for monitoring CYP3A4-mediated drug-drug interactions with a high-throughput assay, which will help to improve the safety of clinical drug combination.

References

Sjovall F, Perner A, Moller M . Empirical mono- versus combination antibiotic therapy in adult intensive care patients with severe sepsis - A systematic review with meta-analysis and trial sequential analysis. J Infect. 2016; 74(4):331-344. DOI: 10.1016/j.jinf.2016.11.013. View

Lv C, Huang L . Xenobiotic receptors in mediating the effect of sepsis on drug metabolism. Acta Pharm Sin B. 2020; 10(1):33-41. PMC: 6977532. DOI: 10.1016/j.apsb.2019.12.003. View

Evans W, Relling M . Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999; 286(5439):487-91. DOI: 10.1126/science.286.5439.487. View

Cotreau M, von Moltke L, Greenblatt D . The influence of age and sex on the clearance of cytochrome P450 3A substrates. Clin Pharmacokinet. 2005; 44(1):33-60. DOI: 10.2165/00003088-200544010-00002. View

Lu J, Li H, Cui D, Zhang Y, Liu S . Enhanced enzymatic reactivity for electrochemically driven drug metabolism by confining cytochrome P450 enzyme in TiO₂ nanotube arrays. Anal Chem. 2014; 86(15):8003-9. DOI: 10.1021/ac502234x. View

Sevrioukova I . Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding. J Biol Chem. 2023; 299(9):105117. PMC: 10470200. DOI: 10.1016/j.jbc.2023.105117. View

Liu N, Yang K, Li W, Pang Z, Zhang Q, Wang J . Evaluation of the inhibition of chlorophenols towards human cytochrome P450 3A4 and differences among various species. Sci Total Environ. 2020; 724:138187. DOI: 10.1016/j.scitotenv.2020.138187. View

Kuramoto S, Kato M, Shindoh H, Kaneko A, Ishigai M, Miyauchi S . Simple Evaluation Method for CYP3A4 Induction from Human Hepatocytes: The Relative Factor Approach with an Induction Detection Limit Concentration Based on the Model. Drug Metab Dispos. 2017; 45(11):1139-1145. DOI: 10.1124/dmd.117.076349. View

Attwa M, Alrabiah H, Mostafa G, Kadi A . Evaluation of Alectinib Metabolic Stability in HLMs Using Fast LC-MS/MS Method: In Silico ADME Profile, P450 Metabolic Lability, and Toxic Alerts Screening. Pharmaceutics. 2023; 15(10). PMC: 10610548. DOI: 10.3390/pharmaceutics15102449. View

10.

Wang Z, Li Q, Huang C, Dong Y, Lang L, Sun W . Determination of CYP450 activities in diabetes mellitus rats by a UHPLC-MS/MS method. J Pharm Biomed Anal. 2022; 224:115191. DOI: 10.1016/j.jpba.2022.115191. View

11.

Xing Y, Yu Q, Zhou L, Cai W, Zhang Y, Bi Y . Cytochrome P450-mediated herb-drug interaction (HDI) of Polygonum multiflorum Thunb. based on pharmacokinetic studies and in vitro inhibition assays. Phytomedicine. 2023; 112:154710. DOI: 10.1016/j.phymed.2023.154710. View

12.

Lauschke V, Shafagh R, Hendriks D, Ingelman-Sundberg M . 3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications. Biotechnol J. 2019; 14(7):e1800347. DOI: 10.1002/biot.201800347. View

13.

Stanley L, Wolf C . Through a glass, darkly? HepaRG and HepG2 cells as models of human phase I drug metabolism. Drug Metab Rev. 2022; 54(1):46-62. DOI: 10.1080/03602532.2022.2039688. View

14.

Kozyra M, Johansson I, Nordling A, Ullah S, Lauschke V, Ingelman-Sundberg M . Human hepatic 3D spheroids as a model for steatosis and insulin resistance. Sci Rep. 2018; 8(1):14297. PMC: 6155201. DOI: 10.1038/s41598-018-32722-6. View

15.

Jang M, Kleber A, Ruckelshausen T, Betzholz R, Manz A . Differentiation of the human liver progenitor cell line (HepaRG) on a microfluidic-based biochip. J Tissue Eng Regen Med. 2019; 13(3):482-494. DOI: 10.1002/term.2802. View

16.

Wang Z, Li W, Li Q, Jing H, Yuan T, Fu G . A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro. Biomed Pharmacother. 2019; 116:109010. DOI: 10.1016/j.biopha.2019.109010. View

17.

Seo J, Li X, Le Y, Mei N, Zhou T, Guo X . High-throughput micronucleus assay using three-dimensional HepaRG spheroids for in vitro genotoxicity testing. Arch Toxicol. 2023; 97(4):1163-1175. DOI: 10.1007/s00204-023-03461-z. View

18.

Seo J, He X, Muskhelishvili L, Malhi P, Mei N, Manjanatha M . Evaluation of an in vitro three-dimensional HepaRG spheroid model for genotoxicity testing using the high-throughput CometChip platform. ALTEX. 2022; 39(4):583-604. DOI: 10.14573/altex.2201121. View

19.

Ning J, Wang W, Ge G, Chu P, Long F, Yang Y . Target Enzyme-Activated Two-Photon Fluorescent Probes: A Case Study of CYP3A4 Using a Two-Dimensional Design Strategy. Angew Chem Int Ed Engl. 2019; 58(29):9959-9963. DOI: 10.1002/anie.201903683. View

20.

He R, Dai Z, Finel M, Zhang F, Tu D, Yang L . Fluorescence-Based High-Throughput Assays for Investigating Cytochrome P450 Enzyme-Mediated Drug-Drug Interactions. Drug Metab Dispos. 2023; 51(10):1254-1272. DOI: 10.1124/dmd.122.001068. View